Researchers have used a molecular genome-editing tool called DNA Typewriter to reconstruct the cellular family tree of a developing mouse embryo, tracking 1.28 million cells over 13.5 days of gestation and mapping how a single fertilized egg multiplies into specialized tissues and organs.
The mammalian body begins as a single fertilized egg. Tracing how that founding cell divides into millions of specialized descendants has long challenged developmental biology. While scientists mapped the complete cell lineage of a transparent roundworm in 1983, generating a comprehensive cell fate map for a mammal that develops hidden in utero was out of reach until now. Two independent research groups turned to genome-editing technology to record cellular divisions directly inside living embryos using DNA-modifying methods.
University of Washington Team Uses DNA Typewriter
Jay Shendure is the scientific director of the Seattle Hub for Synthetic Biology and a professor at the University of Washington School of Medicine. The team injected the components of a tracking system called DNA Typewriter directly into a fertilized mouse egg, allowing the embryo to grow for 13.5 days—equivalent to roughly two-thirds of normal gestation and reaching the stage of organogenesis, when complex organs take shape.
The technology functions much like an airplane black box for embryonic development. The group achieved this latest breakthrough by employing a tracking method named DNA Typewriter, which was developed by Junhong Choi and Jay Shendure. As the cell divides, each daughter cell inherits the sequence of previous stamps.
Writing the record is only half the problem.
Haedong Kim
The updated design allows the sequential genetic stamps to preserve a running log of each division event without fully severing the DNA or erasing earlier records.
Tracing Cells Back to Two Founding Divisions
From that single embryo, the researchers reconstructed a time-calibrated lineage tree comprising 1.28 million transcriptionally profiled cells, which corresponds to roughly 10 percent of all cells in a two-week-old mouse. The Seattle Hub for Synthetic Biology—a collaborative effort between the Allen Institute, UW Medicine, and Biohub—detailed the milestone as the largest cell lineage tree ever assembled for any mammal.
The recording captured a fortuitous edit right after the fertilized egg split in half, creating two independent daughter lineages within the same embryo. When the researchers analyzed these two branches, they found that one branch produced more descendants than the other, but both founding branches contributed almost equal ratios of diverse cell types.
Independent Research Groups Apply Parallel Methods
In independent research published in the journal Cell, a separate team led by molecular biologist Jonathan Weissman of the Massachusetts Institute of Technology used a complementary genome-editing tool. Weissman’s team introduced prime-editing instructions and 35 target DNA sites into mouse embryonic stem cells, which they then injected into developing mouse embryos at the four- to eight-cell stage.
While Shendure’s DNA Typewriter logged divisions sequentially onto an inserted tape from the zygote stage onward, Weissman’s team installed heritable genetic marks at multiple sites across the genome as stem cells integrated into the growing embryo. Both methods produced high-resolution cell fate maps that allowed investigators to trace when specific lineages—such as neural crest cells—committed to their specialized biological functions.
Application to Cancer and Congenital Disease
Mapping the normal trajectory from a single zygote to millions of cells provides a reference model for studying developmental abnormalities. By analyzing the timing of lineage splits, scientists can pinpoint when developmental processes go awry and how congenital malformations, genetic disorders, and cancer arise. Because tumors develop when individual cells accumulate mutations and their descendants proliferate, tracking lineages in this manner could inform the design of therapeutic cells and illuminate how stem cell therapies engraft after transplantation.